Preterm Birth Clinical Trial
— GROWNDUPOfficial title:
The GROWNDUP Study: Pilot to Assess the Feasibility of an RCT for Promoting Growth, Nutrition and Development Through a Specialized Late Preterm Clinic
Verified date | April 2015 |
Source | McMaster University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Interventional |
This pilot study will examine the feasibility of conducting a large randomized clinical
trial (RCT) to examine the role of a novel, specialized follow-up clinic in preventing
complications among late preterm infants (LPTB), born between 34 and 36 weeks gestational
age. 1) Study Process: Success will be achieved if 80% of a target population of 100
subjects is met within the first 6 months of recruitment being initiated. 2) Study
Resources: Success will be achieved if 80% of follow up appointments are scheduled in a
timely manner and if specialized LPTB physicians in the intervention complete assessments
75% of the time in the allocated time frame and 3) Scientific: 95% data completeness on data
collection forms will be identified as success
A specialized LPTB follow-up clinic is innovative as no studies have evaluated such a
programme and standardized follow-up and guidelines for the care of LPTB infants after
discharge from hospital do not exist. Until recently, the incorrect assumption has been that
these infants are healthy and have limited risks compared to term infants.
The study's main question, in addition to assessing the feasibility of this pilot, is: "Do
differences exist in short-tem clinical and developmental outcomes among LPTB infants
enrolled in an RCT who are randomized to a specialized LPTB follow-up programme when
compared to infants randomized to current pragmatic management?" A RCT will provide evidence
for the development of guidelines for the follow-up of LPTB infants in the first 6 months of
life to reduce complications, readmissions and developmental problems.
The results of this study can be generalized to tertiary care and community hospitals and
the general population.
Status | Active, not recruiting |
Enrollment | 100 |
Est. completion date | August 2015 |
Est. primary completion date | August 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A to 1 Month |
Eligibility |
Inclusion Criteria: - singleton or twins born at 34 and 0 days to 36 weeks and 6 days gestational age. Infants admitted to the Level 2 Nursery or newborn nursery at McMaster Children's Hospital or St. Joseph's Healthcare Hamilton or Level 3 Nursery (NICU) at McMaster Children's Hospital will be included. Exclusion Criteria: - triplets and infants with major cardiac anomalies, metabolic disorders, significant gastrointestinal anomalies, intrauterine growth restriction, potential genetic syndromes, neurologic anomalies or severe sepsis/meningitis and LPTB requiring mechanical ventilation (post-delivery room resuscitation with prolonged CPAP or intubation) will be excluded. - mothers who have a history of substance use at any time during pregnancy or alcohol use after confirmation of pregnancy - participants must be able to understand English and speak English as this pilot does not currently have the financial support to sponsor interpreters. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
Canada | McMaster Children's Hospital & McMaster University | Hamilton | Ontario |
Canada | St. Joseph's Hospital | Hamilton | Ontario |
Lead Sponsor | Collaborator |
---|---|
McMaster University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Hospital Readmission | The rates of hospital readmission will be determined for the first six months of life. | 14 months | No |
Primary | Recruitment Rate | Recruitment Rate during first six months of pilot. Reported as the percentage of subjects recruited from those eligible to participate. | 14 months | No |
Secondary | Infant Weight Gain | Weight Gain reported in grams. | 14 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Not yet recruiting |
NCT03418012 -
Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB
|
N/A | |
Not yet recruiting |
NCT03418311 -
Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome
|
N/A | |
Completed |
NCT02993744 -
Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone
|
N/A | |
Active, not recruiting |
NCT02673216 -
Infection and Adverse Pregnancy Outcome
|
||
Completed |
NCT01683565 -
Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood
|
Phase 4 | |
Completed |
NCT01460576 -
Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
|
N/A | |
Completed |
NCT01412931 -
Protein and Ultrasound Indicators of Preterm Birth
|
N/A | |
Completed |
NCT02606058 -
The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?
|
N/A | |
Terminated |
NCT03715530 -
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
|
N/A | |
Completed |
NCT00422526 -
Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial
|
Phase 3 | |
Enrolling by invitation |
NCT04251260 -
Effectiveness of Positioning in Preterm Neonates
|
N/A | |
Completed |
NCT03668860 -
India Dexamethasone and Betamethasone
|
Phase 1 | |
Recruiting |
NCT03638037 -
Correlation Between Maternal Vitamin D Level And Preterm Birth
|
||
Completed |
NCT02225353 -
Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
|
Phase 2 | |
Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
Completed |
NCT03144141 -
Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery
|
N/A | |
Completed |
NCT05210985 -
Examination of the Relationship Between Home Affordances With Development
|
||
Completed |
NCT04811742 -
Effect of Immersion Bathing and Showering Applications on Comfort Level and Physiological Parameters of Newborn
|
N/A |